Sanofi Ventures operates as the corporate venture capital arm of Sanofi.
Sanofi Ventures is the corporate venture capital arm of Sanofi. We have the ability to seed and to lead financings in early-stage companies with innovative ideas and transformative new products and technologies that are of strategic interest to Sanofi. Among these areas are rare diseases, oncology, immunology and inflammation, vaccines, potential cures in other core areas of Sanofi’s business footprint, and digital health and data science solutions.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 15, 2022
Minervax
|
Series C | €22M | Biotechnology | — |
Aug 2, 2022
Empatica
|
Series B | $25.94M | Artificial Intelligence | Yes |
Jun 29, 2022
ReCode Therapeutics
|
Series B | $120M | Biopharma | — |
Oct 22, 2021
Click Therapeutics
|
Series B | $52M | Biotechnology | — |
Oct 21, 2021
ReCode Therapeutics
|
Series B | $210M | Biopharma | — |